What You Should Know
The News: Cellares has raised $257M in Series D financing, bringing its total capital to $612 million. The round was co-led by BlackRock and Eclipse.The Tech: Cellares is building the world's first IDMO (Integrated Development and Manufacturing Organization). Its Cell Shuttle™ and Cell Q™ platforms fully automate the manufacturing and quality control of cell therapies, replacing "artisanal" manual processes.The Scale: The company claims its automated "Smart Factories" can
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
NJEDA Bets $12.5M on Medtech and Maternal Health Startups in New Jersey
What You Should Know
The Investment: The New Jersey Economic Development Authority (NJEDA) has approved a $12.55M commitment to launch two new Strategic Innovation Centers (SICs) focused on medical technology and maternal health.The Hubs: The initiative creates NJ AIM in Camden/Mullica Hill for general medtech and New Baby New Jersey in Trenton for maternal and infant health solutions.The Engine: Both programs will be managed by global accelerator giant Plug and Play, aiming to graduate two
Read More
4DMedical Secures $100M+ to Scale U.S. Respiratory Imaging Rollout
What You Should Know:
- 4DMedical, the leader in software-based respiratory imaging technology, today announced US$100+ million (AU$150 million) in new institutional placement.
- The investment will primarily be leveraged to accelerate U.S. adoption of its class-leading "CT:VQ™" product and significantly boost research and development—bolstering 4D's technology lead in software-based lung imaging. Backed by new institutional funding, 4DMedical is advancing its respiratory imaging
Read More
AnswersNow Secures $40M to Disrupt Broken Autism Support Systems
What You Should Know:
- AnswersNow, the leader in virtual Applied Behavioral Analysis (ABA) therapy, today announced that it has raised $40 million in Series B funding led by HealthQuest Capital, with participation from existing investors Left Lane Capital, Owl Ventures, and others.
- AnswersNow delivers clinically proven outcomes in one-sixth the hours of traditional therapy, creating substantial cost savings for payors while delivering superior results for families.
AnswersNow Scales
Read More
How Crossroads Health Ventures’ $21M Fund Accelerates Indiana Life Sciences
What You Should Know
The News: Crossroads Health Ventures (CHV) has launched a new early-stage venture fund with over $21M in capital to support Indiana-based life sciences startups.The Backers: The fund represents a rare collaboration between the state (IEDC), academia (Indiana University), and three global industry leaders: Eli Lilly (human health), Elanco (animal health), and Corteva (plant health).The Strategy: CHV aims to bridge the early-stage funding gap for companies operating
Read More
Vista AI Secures $29.5M to Scale Automated Scanning Across Brain, Spine, and Prostate
What You Should Know
Vista AI, a provider of automated MRI scanning software for hospitals and imaging centers secures $29.5M in Series B financing, backed by a powerhouse group of new investors including Cedars-Sinai, Intermountain Health, and Tampa General Hospital.
- The funding will accelerate the expansion of the company's FDA-cleared automated MRI scanning platform into new anatomies—including brain, spine, and prostate—while scaling remote scanning services to address the national
Read More
MARS Bioimaging Secures $15M to Scale World’s First Portable Spectral CT Scanners
What You Should Know
- MARS Bioimaging, a New Zealand–headquartered pioneer in medical imaging, secures $15M in Series A funding round. Led by Pacific Channel.
- The capital will be used to scale the commercial adoption of the world’s first portable spectral photon-counting CT scanners—technology that delivers high-resolution, 3D color images to the point of care.
The Spectral Shift: 3D Color vs. Black-and-White
Traditional CT scans are typically low-resolution, black-and-white
Read More
Converge Bio Lands $25M to Replace Trial-and-Error Drug Discovery
What You Should Know
- Converge Bio has announced a $25M Series A funding round led by Bessemer Venture Partners, bringing its total raised to $30M.
- Moving beyond the "AI promise" gap, the company provides end-to-end AI systems that plug directly into existing drug development workflows, already serving over a dozen pharmaceutical and biotech customers to optimize target discovery and protein manufacturing.
The Systemic Pivot: Bridging the Gap Between Promise and Reality
While
Read More
Xella Health Raises $3.7M to Pioneer AI-Powered Menstrual Fluid Diagnostics
What You Should Know
- Xella Health has emerged from stealth with $3.7M in pre-seed financing to build the infrastructure for "decoding" female biology.
- Led by Precursor Ventures, the company is pioneering a first-of-its-kind diagnostic platform that combines menstrual fluid analysis with peripheral blood and AI-powered multi-omics to identify the root causes of chronic conditions like endometriosis, PCOS, and perimenopause.
The Biological Signal: Tapping Into Menstrual
Read More
Mitch Rales Leads $43M Round to Scale VieCure’s AI Oncology Platform
What You Should Know:
- VieCure has raised $43M led by Mitch Rales (co-founder of Danaher) and Northpond Ventures. The funding will scale VieCure's Halo Intelligence™ platform, an AI-powered clinical decision support system that has already increased tumor sequencing rates by 8x for 30,000 patients.
- Through a partnership with Rales' firm New Bearing, VieCure will implement a world-class business system to modernize community oncology clinics, which treat 80% of U.S. cancer
Read More
